Desheng Jing

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

DUSP5 regulates ferroptosis in pancreatic cancer by down-regulating SCD1 expression via ERK1/2.

DUSP5 regulates ferroptosis in pancreatic cancer by down-regulating SCD1 expression via ERK1/2.

Journal: Acta biochimica et biophysica Sinica

Published: July 20, 2026

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.

Journal: ACS nano

Published: April 01, 2026

SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induced ferroptosis.

SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induced ferroptosis.

Journal: Acta biochimica et biophysica Sinica

Published: January 28, 2026

Targeting ACSS2 disrupts metabolic-epigenetic crosstalk to restore apoptosis and temozolomide chemosensitivity in pancreatic neuroendocrine tumors.

Targeting ACSS2 disrupts metabolic-epigenetic crosstalk to restore apoptosis and temozolomide chemosensitivity in pancreatic neuroendocrine tumors.

Journal: Cancer letters

Published: January 19, 2026

Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression.

Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 14, 2025

ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors.

ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 15, 2025

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors.

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors.

Journal: Cell death & disease

Published: January 10, 2025

Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors.

Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors.

Journal: Oncogene

Published: November 06, 2024

Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression.

Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression.

Journal: Cancer research

Published: July 22, 2024

Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

Journal: Cancer cell

Published: June 11, 2024

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.

Journal: Human cell

Published: May 12, 2024

The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.

The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.

Journal: Cancer letters

Published: December 20, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026